Michael J. Leathley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael J. Leathley has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Caroline Watkins
Stroke Research Team, School of Nursing and Midwifery, University of Lancashire, Preston, UK
5 shared publications - Beverley French
School of Health, University of Central Lancashire, Victoria Street, Preston PR1 2HE, UK
3 shared publications - Denise Forshaw
Lancashire Clinical Trials Unit, University of Central Lancashire, Preston, UK
3 shared publications - Lois H. Thomas
School of Health, University of Central Lancashire, Preston, UK
3 shared publications - Brenda Roe
Evidence-Based Practice Research Centre, Edge Hill University, Ormskirk, UK
2 shared publications - Christopher Richard Burton
School of Health Sciences University of East Anglia Norwich UK
2 shared publications
Latest Publications
- Open Access
- 21 August 2015
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 15 (1) , 68
Assessing fidelity to treatment delivery in the ICONS (Identifying Continence OptioNs after Stroke) cluster randomised feasibility trial
The implementation of strategies to monitor and enhance treatment fidelity is of paramount importance in trials of complex interventions. A recent framework published by the National Institutes of Health Behavior Change Consortium recommends addressing five areas of treatment fidelity, one of which is delivery of treatment. This study aimed to explore fidelity to treatment delivery of the ICONS intervention (a systematic voiding programme [SVP]). This included exploring the feasibility of a method to assess fidelity to treatment delivery and collecting preliminary evidence of the level of fidelity to SVP delivery in order to inform strategies for improving fidelity in a future trial. Delivery of treatment was recorded by nurses through completion of daily clinical logs, which included: a voiding interval, proposed voiding times and actual voiding times. The a priori method for assessment of fidelity – comparing actual voiding times with proposed voiding times – was trialled on a small amount of data. Due to errors in documentation of the voiding intervals and proposed voiding times it was not possible to assess fidelity directly as planned. A new method was devised, which included identification of ‘key quality indicators’. This new approach to assessing fidelity used key quality indicators based upon presence of the data needed to make the comparison between proposed and actual voiding times. The proportion of clinical logs with correct documentation of voiding intervals and proposed voiding times was less than 40 %. For clinical logs with correct documentation, an actual voiding time within 30 min of the proposed voiding time was identified on approximately 55 % of occasions. Lessons learnt from this study have implications for the future ICONS definitive trial and for other trials of complex interventions. Implementation of a complex intervention may often deviate from what is intended. While careful consideration should be given to the best method of fidelity assessment, an iterative approach allowing flexibility to adapt pre-planned methods is recommended within feasibility trials. As fidelity to treatment delivery in the ICONS feasibility trial appeared to be relatively low, more attention to implementation strategies will be required in the definitive trial. Identifier: ISRCTN08609907 ; date registered: 07/07/2010.
- 21 August 2015
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 15 (1) , 68
Open AccessAssessing fidelity to treatment delivery in the ICONS (Identifying Continence OptioNs after Stroke) cluster randomised feasibility trial
The implementation of strategies to monitor and enhance treatment fidelity is of paramount importance in trials of complex interventions. A recent framework published by the National Institutes of Health Behavior Change Consortium recommends addressing five areas of treatment fidelity, one of which is delivery of treatment. This study aimed to explore fidelity to treatment delivery of the ICONS intervention (a systematic voiding programme [SVP]). This included exploring the feasibility of a method to assess fidelity to treatment delivery and collecting preliminary evidence of the level of fidelity to SVP delivery in order to inform strategies for improving fidelity in a future trial. Delivery of treatment was recorded by nurses through completion of daily clinical logs, which included: a voiding interval, proposed voiding times and actual voiding times. The a priori method for assessment of fidelity – comparing actual voiding times with proposed voiding times – was trialled on a small amount of data. Due to errors in documentation of the voiding intervals and proposed voiding times it was not possible to assess fidelity directly as planned. A new method was devised, which included identification of ‘key quality indicators’. This new approach to assessing fidelity used key quality indicators based upon presence of the data needed to make the comparison between proposed and actual voiding times. The proportion of clinical logs with correct documentation of voiding intervals and proposed voiding times was less than 40 %. For clinical logs with correct documentation, an actual voiding time within 30 min of the proposed voiding time was identified on approximately 55 % of occasions. Lessons learnt from this study have implications for the future ICONS definitive trial and for other trials of complex interventions. Implementation of a complex intervention may often deviate from what is intended. While careful consideration should be given to the best method of fidelity assessment, an iterative approach allowing flexibility to adapt pre-planned methods is recommended within feasibility trials. As fidelity to treatment delivery in the ICONS feasibility trial appeared to be relatively low, more attention to implementation strategies will be required in the definitive trial. Identifier: ISRCTN08609907 ; date registered: 07/07/2010.
- Open Access
- 23 December 2014
- Published by Springer Nature in Trials
- Vol. 15 (1) , 509
Identifying continence options after stroke (ICONS): a cluster randomised controlled feasibility trial
Urinary incontinence (UI) affects half of patients hospitalised after stroke and is often poorly managed. Cochrane systematic reviews have shown some positive impact of conservative interventions (such as bladder training) in reducing UI, but their effectiveness has not been demonstrated with stroke patients.
- 23 December 2014
- Published by Springer Nature in Trials
- Vol. 15 (1) , 509
Open AccessIdentifying continence options after stroke (ICONS): a cluster randomised controlled feasibility trial
Urinary incontinence (UI) affects half of patients hospitalised after stroke and is often poorly managed. Cochrane systematic reviews have shown some positive impact of conservative interventions (such as bladder training) in reducing UI, but their effectiveness has not been demonstrated with stroke patients.
- Open Access
- 14 November 2013
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 13 (1) , 125
The challenges of implementing a telestroke network: a systematic review and case study
The use of telemedicine in acute stroke care can facilitate rapid access to treatment, but the work required to embed any new technology into routine practice is often hidden, and can be challenging. We aimed to collate recommendations and resources to support telestroke implementation.
- 14 November 2013
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 13 (1) , 125
Open AccessThe challenges of implementing a telestroke network: a systematic review and case study
The use of telemedicine in acute stroke care can facilitate rapid access to treatment, but the work required to embed any new technology into routine practice is often hidden, and can be challenging. We aimed to collate recommendations and resources to support telestroke implementation.
- Open Access
- 5 December 2012
- Published by Springer Nature
Exercise training early after stroke: a feasibility study
- 5 December 2012
- Published by Springer Nature
Open AccessExercise training early after stroke: a feasibility study
- Open Access
- 20 May 2011
- Published by Springer Nature in Trials
- Vol. 12 (1) , 131
Study protocol: ICONS: Identifying continence options after stroke: A randomised trial
Urinary incontinence following acute stroke is common, affecting between 40%-60% of people in hospital after a stroke. Despite the availability of clinical guidelines for urinary incontinence and urinary incontinence after stroke, national audit data suggest incontinence is often poorly managed. Conservative interventions (e.g. bladder training, pelvic floor muscle training and prompted voiding) have been shown to have some effect with participants in Cochrane systematic reviews, but have not had their effectiveness demonstrated with stroke patients.
- 20 May 2011
- Published by Springer Nature in Trials
- Vol. 12 (1) , 131
Open AccessStudy protocol: ICONS: Identifying continence options after stroke: A randomised trial
Urinary incontinence following acute stroke is common, affecting between 40%-60% of people in hospital after a stroke. Despite the availability of clinical guidelines for urinary incontinence and urinary incontinence after stroke, national audit data suggest incontinence is often poorly managed. Conservative interventions (e.g. bladder training, pelvic floor muscle training and prompted voiding) have been shown to have some effect with participants in Cochrane systematic reviews, but have not had their effectiveness demonstrated with stroke patients.
- 1 June 2004
- Published by SAGE Publications in Clinical Rehabilitation
- Vol. 18 (4) , 438-443
Predicting spasticity after stroke in those surviving to 12 months
Objective: To measure muscle tone in a cohort of patients 12 months after stroke and develop a preliminary model, using data recorded routinely after stroke, to predict who will develop spasticity. Design: A cohort study. Setting: Initially hospitalized but subsequently community-dwelling stroke survivors in Liverpool, United Kingdom. Subjects: One hundred and six consecutively presenting stroke patients surviving to 12 months. Main outcome measures: Spasticity measured at a range of joints using the Tone Assessment Scale. Results: The Tone Assessment Scale revealed spasticity in 38 (36%) patients and more severe spasticity in 21 (20%) of the 106 patients. Logistic regression analysis revealed that lower day 7 Barthel Index score and early arm or leg weakness were significant predictors of abnormal muscle tone; and lower day 7 Barthel Index score, left-sided weakness and ever smoked to be significant predictors of more severe muscle tone. Conclusions: Using the models, it may be possible to predict whether or not spasticity will develop in patients 12 months after stroke. The utility of the models is aided by their use of predictor variables that are routinely collected as part of stroke care in hospital and which are easy to measure. The models need testing prospectively in a new cohort of patients in order to test their validity, reliability and utility and to determine if other data could improve their efficiency.
- 1 June 2004
- Published by SAGE Publications in Clinical Rehabilitation
- Vol. 18 (4) , 438-443
Predicting spasticity after stroke in those surviving to 12 months
Objective: To measure muscle tone in a cohort of patients 12 months after stroke and develop a preliminary model, using data recorded routinely after stroke, to predict who will develop spasticity. Design: A cohort study. Setting: Initially hospitalized but subsequently community-dwelling stroke survivors in Liverpool, United Kingdom. Subjects: One hundred and six consecutively presenting stroke patients surviving to 12 months. Main outcome measures: Spasticity measured at a range of joints using the Tone Assessment Scale. Results: The Tone Assessment Scale revealed spasticity in 38 (36%) patients and more severe spasticity in 21 (20%) of the 106 patients. Logistic regression analysis revealed that lower day 7 Barthel Index score and early arm or leg weakness were significant predictors of abnormal muscle tone; and lower day 7 Barthel Index score, left-sided weakness and ever smoked to be significant predictors of more severe muscle tone. Conclusions: Using the models, it may be possible to predict whether or not spasticity will develop in patients 12 months after stroke. The utility of the models is aided by their use of predictor variables that are routinely collected as part of stroke care in hospital and which are easy to measure. The models need testing prospectively in a new cohort of patients in order to test their validity, reliability and utility and to determine if other data could improve their efficiency.